Effects of ipragliflozin, a selective sodium–glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials

Our aim was to examine the effects of ipragliflozin, a selective sodium–glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus (T2DM). We conducted a pooled analysis of double-blind trials of Japanese T2DM patients, randomized to 50 mg ipragliflozin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetol Int
Main Authors: Kashiwagi, Atsunori, Yoshida, Satoshi, Kawamuki, Kosei, Nakamura, Ichiro, Kazuta, Kenichi, Ueyama, Eiji, Takahashi, Hideyuki, Akiyama, Noriko, Kondo, Yoshinori, Ogihara, Toshio
Formato: Artigo
Idioma:Inglês
Publicado: Springer Japan 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224932/
https://ncbi.nlm.nih.gov/pubmed/30603310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-016-0283-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares